EP3599237
PHARMACEUTICAL COMPOSITION OF THE GLUCOSYLCERAMIDE SYNTHASE INHIBITOR ELIGLUSTAT FOR THE TREATMENT OF GAUCHER'S DISEASE COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P450 METABOLISM OF THE PATIENT
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
24.11.2010EP published:
24.3.2021EP application number:
19182732.8
EPO information:
European Patent Register
Max expiry date:
23.11.2030
Title:
PHARMACEUTICAL COMPOSITION OF THE GLUCOSYLCERAMIDE SYNTHASE INHIBITOR ELIGLUSTAT FOR THE TREATMENT OF GAUCHER'S DISEASE COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P450 METABOLISM OF THE PATIENT
Timeline
Today
24.11.2010EP application
24.3.2021EP Publication
Owner
Name:
Genzyme CorporationAddress:
50 Binney Street, Cambridge, MA 02142, US
Inventor
Name:
LIU, HanlanAddress:
Lexington, MA Massachusetts 02420, US
Name:
WILLIS, ChrisAddress:
Southborough, MA Massachusetts 01772, US
Name:
BHARDWAJ, RenuAddress:
Ashland, MA Massachusetts 01721, US
Name:
COPELAND, Diane P.Address:
Billerica, MA Massachusetts 01862, US
Name:
HARIANAWALA, AbizerAddress:
Acton, MA Massachusetts 01720, US
Name:
SKELL, JeffreyAddress:
Westborough, MA Massachusetts 01581, US
Name:
MARSHALL, JohnAddress:
Bridgewater, NJ New Jersey 08807, US
Name:
KOCHLING, JianmeiAddress:
Wellesley, MA Massachusetts 02482, US
Name:
PALACE, GerardAddress:
Framingham, MA Massachusetts 01701, US
Name:
PETERSCHMITT, JudithAddress:
Watertown, MA Massachusetts 02472, US
Name:
SIEGEL, CraigAddress:
Woburn, MA Massachusetts 01801, US
Name:
CHENG, SengAddress:
Natick, MA Massachusetts 01760, US
Priority
Number:
26474809 PDate:
27.11.2009Country:
US
Classification
Categories:
C07D 405/06, C07D 319/16, A61K 31/4025, A61P 35/00